Literature DB >> 10477577

Human rheumatoid factor production is dependent on CD40 signaling and autoantigen.

D Kyburz1, M Corr, D C Brinson, A Von Damm, H Tighe, D A Carson.   

Abstract

High-affinity pathologic rheumatoid factor (RF) B cells occur in autoimmune diseases such as rheumatoid arthritis, but are deleted in healthy individuals. The reasons for the survival and differentiation of these autoreactive B cells in rheumatoid arthritis are not known. Previous studies in mice transgenic for a human IgM RF have shown that peripheral encounter with soluble human IgG leads to deletion of high-affinity RF B cells; however, deletion can be prevented when concomitant T cell help is provided. This study aimed to further discern the minimal factors necessary not only for the in vivo survival of RF B cells, but also for their differentiation into Ab-secreting cells. The combination of MHC class II-reactive T cells and Ag induced the production of RF in human IgM RF transgenic mice, while either stimulus alone was ineffective. Neutralizing Abs against CD40 ligand (CD40L), but not against IL-4 or IL-15, abrogated IgM-RF production. Moreover, blockade of CD40L-CD40 allowed IgG to delete the RF precursor cells. Most importantly, activating Abs to CD40 could substitute entirely for T cell help in promoting the survival of RF precursors and in stimulating RF synthesis in T cell deficient animals. The data indicate that CD40 signaling alone can prevent deletion of RF B cells by Ag and in the presence of IgG is sufficient to trigger RF synthesis. The results suggest that selective induction of apoptosis in high-affinity RF B cells may be achieved by blockade of CD40L-CD40 interaction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477577

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Targeting CD40L: a promising therapeutic approach.

Authors:  Dimitris Daoussis; Andrew P Andonopoulos; Stamatis-Nick C Liossis
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

2.  Persistence of high CD40 and CD40L expression after restorative proctocolectomy for ulcerative colitis.

Authors:  Lino Polese; Imerio Angriman; De Franchis Giuseppe; Attilio Cecchetto; Giacomo-C Sturniolo; D'Inca Renata; Marco Scarpa; Cesare Ruffolo; Lorenzo Norberto; Mauro Frego; Davide-F D'Amico
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

Review 3.  Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications.

Authors:  Armen Yuri Gasparyan; Antonios Stavropoulos-Kalinoglou; Dimitri P Mikhailidis; Karen M J Douglas; George D Kitas
Journal:  Rheumatol Int       Date:  2011-02       Impact factor: 2.631

4.  RNA-seq and Network Analysis Reveal Unique Chemokine Activity Signatures in the Synovial Tissue of Patients With Rheumatoid Arthritis.

Authors:  Runrun Zhang; Yehua Jin; Cen Chang; Lingxia Xu; Yanqin Bian; Yu Shen; Yang Sun; Songtao Sun; Steven J Schrodi; Shicheng Guo; Dongyi He
Journal:  Front Med (Lausanne)       Date:  2022-05-04

Review 5.  Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.

Authors:  Qianxia Zhang; Dario A A Vignali
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

6.  Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7.

Authors:  Tomoko Hayashi; Christine S Gray; Michael Chan; Rommel I Tawatao; Lisa Ronacher; Maureen A McGargill; Sandip K Datta; Dennis A Carson; Maripat Corr
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

Review 7.  CD154: the atherosclerotic risk factor in rheumatoid arthritis?

Authors:  Ghada S Hassan; Daniel Yacoub; Nada Alaaeddine; Amal Nadiri; Yahye Merhi; Walid Mourad
Journal:  Arthritis Res Ther       Date:  2013-02-22       Impact factor: 5.156

Review 8.  CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Nada Alaaeddine; Ghada S Hassan; Daniel Yacoub; Walid Mourad
Journal:  Clin Dev Immunol       Date:  2011-10-24

Review 9.  Auto-antibodies and autoreactive T-cells in rheumatoid arthritis: pathogenetic players and diagnostic tools.

Authors:  Günter Steiner
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817

10.  Rituximab and its potential for the treatment of rheumatoid arthritis.

Authors:  Adam Bryant; John Moore
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.